Improving and Accelerating Therapeutic Development for Nervous System Disorders
Publisher: National Academies Press 2013
Number of pages: 116
The aim was to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline.
Home page url
Download or read it online for free here:
by J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.
- U.S. Department of Health and Human Services
The publication, Approved Drug Products (commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act.
by Drug Effectiveness Review Project - Oregon Health & Science University
Contents: Agents for Overactive Bladder; Atypical Antipsychotic Drugs; Beta Adrenergic Blockers; Calcium Channel Blockers; Constipation Drugs; Inhaled Corticosteroids; Drugs for Neuropathic Pain; Newer Antiemetics; Newer Antihistamines; etc.
by Niels Bindslev - Co-Action Publishing
This book is a survey of, and evaluates, analytical tools used to determine equilibrium effects of the interactions between ligands and receptive units as obtained from dose-response experimentation and from combinatorial drug therapy.